Le Lézard13d
Statement from the Chief Public Health Officer of Canada on the Increase in Measles Cases and the Risk to People in Canada
Protect Yourself and Your Family In 2024, we saw a sharp increase in measles cases globally compared to 2023. In Canada this concerning trend has continued with more cases reported in the first two ...
Ferring Inc. Receives Health Canada Approval for PrREBYOTA® (fecal microbiota, live)
Ferring Inc. announced Health Canada has issued a Notice of Compliance, approving REBYOTA® (fecal microbiota, live), a novel first-in-class microbiome-restoration therapy indicated for the prevention ...
Medical News Today28d
Vowst (fecal microbiota spores, live-brpk) and cost
How does the cost of Vowst compare with the cost of Rebyota? The cost of Vowst compared with the cost of Rebyota depends on several factors. These include your treatment plan, insurance coverage ...
Le Lézard10mon
Microplates Market to Reach USD 1,301.08 million by 2032, Growing at an 4.50% CAGR - Credence Research
The Global Microplates Market is experiencing steady growth, driven by the increasing adoption of high-throughput screening (HTS) in drug discovery, rising demand for automated laboratory solutions, ...
Medscape1y
New and Emerging Options for Treating Recurrent C difficile
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
pharmaphorum2y
Huge inequalities found in access to myeloma clinical trials in Europe, says MPE
Myeloma Patients Europe (MPE) has identified significant inequalities among patients’ access to myeloma clinical trials in Central and Eastern Europe (CEE) in a first-of-its-kind advocacy ...